Case ReportOrthostatic hypotension secondary to CRMP-5 paraneoplastic autonomic neuropathy
Introduction
Paraneoplastic neuropathies are caused by mechanisms not related to metastases, metabolic disturbance, infections, coagulopathy or side-effects of cancer treatment. Autonomic neuropathy is characterised by subacute features including gastrointestinal pseudo-obstruction, bladder dysfunction, impotence, pupillomotor dysfunction and orthostatic hypotension [1].
The collapsin response mediator protein 5 (CRMP-5) autoantibody is predominantly associated with small cell lung cancers (SCLC) and thymoma. It is one of only a few paraneoplastic antibodies associated with autonomic neuropathy [2], [3], [4].
Such neuropathies generally present with a constellation of autonomic abnormalities. To our knowledge orthostatic hypotension has not been described as the sole feature of a paraneoplastic neuropathy.
Section snippets
Case report
A 66-year-old man was admitted under our oncology/palliative care unit with postural dizziness causing recurrent conscious collapse. He had a history of SCLC diagnosed 2 years prior, at limited stage, and treated with radical chemoradiotherapy including four cycles of cisplatin and etoposide (cumulative doses 1800 mg and 2640 mg, respectively). His medical history was also significant for an ex-smoking history of 30 pack-years.
Six weeks prior to this admission, he was found to have recurrent
Discussion
We present a patient who fulfils the criteria for a definite paraneoplastic syndrome, defined as, “a non-classical syndrome with onconeural antibodies and cancer that develops within 5 years of the diagnosis of the neurological disorder” [5].
A paraneoplastic aetiology is supported in this case by the subacute onset of symptoms, the presence of CRMP-5 antibodies which have a strong association with autonomic neuropathy [2], the strongly positive titre, and the exclusion of other likely causes.
Conflicts of interest/disclosures
The authors declare that they have no financial or other conflicts of interest in relation to this research and its publication.
References (8)
Autonomic peripheral neuropathy
Lancet
(2005)- et al.
Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations
Curr Opin Neurol
(2011) - et al.
CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity
Ann Neurol
(2001) - et al.
Antibodies and neuronal autoimmune disorders of the CNS
J Neurol
(2010)
Cited by (12)
Gastrointestinal dysfunction in neuroinflammatory diseases: Multiple sclerosis, neuromyelitis optica, acute autonomic ganglionopathy and related conditions
2021, Autonomic Neuroscience: Basic and ClinicalCitation Excerpt :It is frequently associated with a paraneoplastic syndrome, namely, small cell lung carcinoma. In terms of its GI symptoms, CMP-5 causes autonomic neuropathy and enteric neuropathy (constipation) (Koike and Sobue, 2013; Neal et al., 2014). Sjögren's syndrome (SjS) is an autoimmune disease that mainly affects the lacrimal and salivary glands, but can also affect other organs such as the lungs, kidneys, and central and peripheral nervous system.
Treatment and Management of Autoimmune Neuropathies
2021, Neuromuscular Disorders: Treatment and ManagementApatinib successfully administered in malignant tumour patients with severe hypotension: a case series, literature review, and considerations for treatment
2023, Journal of International Medical ResearchAutoimmunity and postural orthostatic tachycardia syndrome: Implications in diagnosis and management
2023, Cleveland Clinic Journal of MedicineSecondary hypertension of other type
2019, Secondary Hypertension: Screening, Diagnosis and TreatmentHypotension as a symptom of autonomic neuropathy in patients with advanced malignancies
2019, Biomedical Papers